Daiichi Sankyo Company, Limited
OTC: DSKYF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Hiroyuki Okuzawa
- Employees
- 18,726
- Headquarters
- Tokyo, Japan
- IPO year
- 2008
- Market cap
- $30.2B
- Website
- https://www.daiichisankyo.com
Loading DSKYF…
Loading profile data…Frequently asked questions about DSKYF
What does Daiichi Sankyo Company, Limited (DSKYF) do?
Daiichi Sankyo Company, Limited operates as a global pharmaceutical powerhouse, dedicated to the research, development, manufacturing, and worldwide commercialization of a wide array of medicinal products. The company boasts an extensive portfolio of therapeutics spanning numerous health conditions. In oncology, its offerings include trastuzumab...
Where does DSKYF trade?
Daiichi Sankyo Company, Limited (DSKYF) trades on the Other OTC.
What sector is DSKYF in?
Daiichi Sankyo Company, Limited (DSKYF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Daiichi Sankyo Company, Limited?
Hiroyuki Okuzawa is the chief executive officer of Daiichi Sankyo Company, Limited (DSKYF).
Where is Daiichi Sankyo Company, Limited headquartered?
Daiichi Sankyo Company, Limited is headquartered in Japan.
Does DSKYF pay a dividend?
Yes — Daiichi Sankyo Company, Limited (DSKYF) paid a trailing twelve-month dividend of USD 0.51 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did DSKYF go public?
Daiichi Sankyo Company, Limited (DSKYF) completed its initial public offering in 2008.